SITC 2024: Bispecific Post-Conference Report

Our bispecific experts have screened the abstracts presented at the 39th SITC Annual Meeting, held in Houston from the 6th to 10th of November 2024, and identified 86 abstracts (20 clinical and 66 preclinical) associated with records on Beacon Bispecific. These have been analyzed and listed in our Post-Conference Report.

SITC 2024: Bispecific Abstract Highlights

This post-conference report sample provides a guide to the Bispecific-relevant abstracts presented at the SITC Annual Meeting.

Explore a list of each abstract with information on developmental phase, target, asset, disease indication, trial sponsor, and more. Download your free copy today.

You May Also Be Interested In…

What is Beacon?

Beacon is a world leading data analysis tool for preclinical and clinical trial information. With unrivalled granularity of search function, data quality, and exhaustiveness, Beacon provides timely information and gives you confidence to progress your targeted drug therapies to patients.

Learn more about how our clinical trials and drug database solutions can be tailored to your research requirements

Find out more

Menu
Search Icon
Close Icon
Search